About the Product

Description


Oxcelzine 150 Tablet contains Oxcarbazepine 150 mg, an anticonvulsant medicine used to manage and prevent epileptic seizures and focal onset seizures in adults and children. It works by stabilizing neuronal membranes and reducing excessive electrical signals in the brain that trigger seizures.

Oxcarbazepine belongs to the neurology and CNS therapy segment and is commonly prescribed by neurologists and general physicians for long-term seizure control. It offers improved tolerability compared to older antiepileptic drugs, making it suitable for chronic management and combination therapy.

Due to its consistent clinical demand, Oxcelzine 150 remains a highly profitable product for PCD pharma franchise partners, wholesalers, and institutional suppliers. It is also available for bulk distribution, export, and third-party manufacturing with competitive business margins.

Dizziness, drowsiness, nausea, headache, fatigue, blurred vision, imbalance, vomiting, or tremors. In rare cases, it may cause low sodium levels, mood changes, or skin reactions.

Used in the treatment of partial seizures, generalized tonic-clonic seizures, and epilepsy. It may also be prescribed as adjunct therapy in patients who do not respond adequately to other antiepileptic drugs.

Take Oxcelzine 150 Tablet exactly as advised. Do not stop suddenly as it may worsen seizures. Inform your doctor if pregnant, planning pregnancy, breastfeeding, or taking other seizure medicines. Avoid driving or operating machinery until effects are known.

Store below 25°C in a cool, dry place away from sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions